First Tracks Biotherapeutics, Inc. (TRAX) Reports Q2 Loss of $0.95
Tweet
Share
E-mailGet Alerts TRAX Hot Sheet
Join SI Premium – FREE
First Tracks Biotherapeutics, Inc. (NASDAQ: TRAX) reported Q2 EPS of ($0.95).
For earnings history and earnings-related data on First Tracks Biotherapeutics, Inc. (TRAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- Scinai posts H1 2026 results with wider operating loss, net gain
- CrowdStrike (CRWD) Reiterated at Overweight by Cantor Fitzgerald as CEO Departs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
